An innovative specialty Pharmaceutical company which is driven to deliver relief for patients who suffer from rarer conditions. Our first product launched in the UK was Bramox ® (midodrine), the first medicine to be licensed in the UK to treat severe orthostatic hypotension due to autonomic dysfunction.